Ground breaking deal signed at Arab Health with Roche Diagnostics and Dr Sulaiman Al Habib Medical Group

The groundbreaking deal will see Roche Diagnostics Total Lab Automisation (TLA) solutions installed in four leading hospitals within Riyadh, Kingdom of Saudi Arabia.

Furthering the advancement of modern healthcare Roche Diagnostics TLA solutions provide an exceptionally high level of quality and continuity in the laboratory.

This means reduced manual intervention during the diagnostic process, in turn this significantly minimizing the element of human error occurring.

The official signature ceremony was attended by Roche Diagnostics President EMEA-LATAM, Dr. Michael Heuer and Dr. Ibrahim Alomar, Vice President for Laboratories Affairs at Dr Sulaiman Al Habib Medical Group.

Commenting at the ceremony, Roche Diagnostics President EMEA-LATAM, Dr. Michael Heuer, said, "This ground breaking deal embodies our commitment to providing innovative healthcare solutions to the private and public sector as well as being a testimony to the importance the KSA market holds for us. What better way to evidence this than through joining forces with one of the largest providers of comprehensive healthcare services in the region; Dr Sulaiman Al Habib Medical Group."

Dr. Ibrahim Alomar, Vice President for Laboratories Affairs at Dr Sulaiman Al Habib Medical Group, added, "We are confident that Roche Diagnostics' broad range of innovative diagnostic tests and systems will play a pivotal role in the advancement of integrated healthcare solutions offered at Dr Sulaiman Al Habib Medical Group and cover the early detection, targeted screening, evaluation and monitoring of disease."

Roche Diagnostics is active in all market segments, from scientific research and clinical laboratory systems to patient self-monitoring.